{
    "title": "AstraZeneca, Oxford allowed to resume COVID-19 vaccine trial in U.S. -WSJ",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-8873539/AstraZeneca-Oxford-allowed-resume-COVID-19-vaccine-trial-U-S--WSJ.html",
    "date": "2020-10-23",
    "keywords": [
        "trial",
        "vaccine",
        "covid19",
        "oxford",
        "health",
        "university",
        "week",
        "astrazeneca",
        "hold",
        "participant",
        "month",
        "inc",
        "resumption",
        "candidate",
        "plc",
        "street",
        "journal",
        "friday",
        "person",
        "matter",
        "tuesday",
        "food",
        "drug",
        "administration",
        "review",
        "situation",
        "comment",
        "latestage",
        "companys",
        "inflammatory",
        "disorder",
        "transverse",
        "myelitis",
        "kingdom",
        "brazil",
        "south",
        "africa",
        "regulator",
        "investigation",
        "case",
        "frontrunner",
        "race",
        "data",
        "pfizer",
        "moderna",
        "time",
        "johnson",
        "stage",
        "illness",
        "study",
        "reporting",
        "munsif",
        "vengattil",
        "carl",
        "anil",
        "dsilva",
        "rosalba",
        "obrien"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}